Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T98089 | Target Info | |||
Target Name | Deoxycytidine kinase (DCK) | ||||
Synonyms | dCK | ||||
Target Type | Literature-reported Target | ||||
Gene Name | DCK | ||||
Biochemical Class | Kinase | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | Cladribine | Ligand Info | |||
Canonical SMILES | C1C(C(OC1N2C=NC3=C(N=C(N=C32)Cl)N)CO)O | ||||
InChI | 1S/C10H12ClN5O3/c11-10-14-8(12)7-9(15-10)16(3-13-7)6-1-4(18)5(2-17)19-6/h3-6,17-18H,1-2H2,(H2,12,14,15)/t4-,5+,6+/m0/s1 | ||||
InChIKey | PTOAARAWEBMLNO-KVQBGUIXSA-N | ||||
PubChem Compound ID | 20279 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 2ZIA C4S dCK variant of dCK in complex with cladribine+UDP | ||||||
Method | X-ray diffraction | Resolution | 1.80 Å | Mutation | Yes | [1] |
PDB Sequence |
RIKKISIEGN
29 IAAGKSTFVN39 ILKQLSEDWE49 VVPEPVARWS59 NVGGNVLQMM85 YEKPERWSFT 95 FQTYACLSRI105 RAQLASLNAE120 KPVLFFERSV130 YSDRYIFASN140 LYESESMNET 150 EWTIYQDWHD160 WMNNQFGQSL170 ELDGIIYLQA180 TPETCLHRIY190 LRGRNEEQGI 200 PLEYLEKLHY210 KHESWLLHRT220 LKTNFDYLQE230 VPILTLDVNE240 DFKDKYESLV 250 EKVKEFLSTL260
|
|||||
|
||||||
PDB ID: 2ZI9 C4S-E247A dCK variant of dCK in complex with cladribine+ADP | ||||||
Method | X-ray diffraction | Resolution | 2.51 Å | Mutation | Yes | [1] |
PDB Sequence |
TRIKKISIEG
28 NIAAGKSTFV38 NILKQLSEDW48 EVVPEPVARW58 SNVQSTQDEF68 EELTMSQKNG 78 GNVLQMMYEK88 PERWSFTFQT98 YACLSRIRAQ108 LASLNGKLKD118 AEKPVLFFER 128 SVYSDRYIFA138 SNLYESESMN148 ETEWTIYQDW158 HDWMNNQFGQ168 SLELDGIIYL 178 QATPETCLHR188 IYLRGRNEEQ198 GIPLEYLEKL208 HYKHESWLLH218 RTLKTNFDYL 228 QEVPILTLDV238 NEDFKDKYAS248 LVEKVKEFLS258 TL
|
|||||
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Elucidation of different binding modes of purine nucleosides to human deoxycytidine kinase. J Med Chem. 2008 Jul 24;51(14):4219-25. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.